In view of today's health system in the United States, which is a bundled single-payor system based on a patient's acute and post-acute care, reduction in the length of hospitalization and cost of care is of utmost importance to hospitals all over the country [3] . There are very little data to date examining the inpatient cost and length of stay (LOS) for patients who have undergone inpatient ERCP. The Secondary goal of our study was to determine the economic impact of ERCPs on the health care system in the United States, by estimating the LOS and cost for ERCP-related hospitalizations over the same time frame.
Patients and methods

Data source
The National Inpatient Sample (NIS) was created by the Agency for Healthcare Research and Quality, which is the largest allpayer inpatient database available in the United States. This constitutes all discharge data across 45 states [4] . These data hav been used in the past to analyze national trends in outcomes for various diagnoses and major procedures; hospitalization rates, healthcare access and disparity of care. The NIS represents approximately 20 % of US community hospitals and they provide sampling weights to project national estimates. Each individual hospitalization is deidentified and maintained as a unique entry with a primary discharge diagnosis and fewer than 24 secondary diagnoses. It also contains information on demographics, comorbidities, insurance status, primary and secondary procedures, hospitalization outcome, LOS and cost of care, with safeguards to protect patient, physician and hospital privacy. Note that the variables of hospital location, region and teaching status were not reported in the dataset for the year 2012 -2013. The NIS data have been compared against data sources from The American Hospital Association Annual Survey Database, The National Hospital Discharge Survey from The National Center for Health Statistics, and MedPAR inpatient data from the Centers for Medicare and Medicaid Services. Furthermore, annual data quality assessments are performed, thus guaranteeing the external and internal validity of the database.
Study population
Using the NIS we identified in-hospital ERCPs 
Definition of variables
NIS variables were used to identify patient demographics. Hospitals with an Accreditation Council for Graduate Medical Education (ACGME)-accredited residency program, which were members of the Council of Teaching Hospitals, and/or had fulltime equivalent interns and a resident-to-patient ratio ≥ 0.25 were considered as teaching hospitals. Hospital location (rural/ urban) and bed size were also taken into account. Because the NIS represents 20 % of the stratified US hospital sample, utilization rates were calculated by dividing the number of ERCP procedures performed, available in the NIS dataset, in a given year divided by 20 % of the US census population aged 18 years or older for that year. Deyo modification of the Charlson Comorbidity Index (CCI) was used to define the severity of comorbid conditions. That contains 17 comorbid conditions with differential weights, with scores ranging from 0 to 33. The LOS for each hospitalization was calculated after excluding those who died during their stay. Cost of hospitalization (COH) was determined after merging data with cost-to-charge ratio files available from the Healthcare Cost and Utilization Project (HCUP) website. The total cost of each hospitalization was determined by multiplying the cost-to-charge ratio with the total hospital charge. Inflation was accounted for by adjusting the cost of each year in reference to the 2016 US dollar value using Consumer Price Index data.
Statistical analysis SAS 9.4 (SAS Institute Inc, Cary, North Carolina) was used for the analyses. Nationally representative estimates were produced using the weight variable provided by the NIS. The categorical variables are expressed in terms of the percentage (%) of the total study population while continuous variables are expressed in terms of mean with its standard error. For trend analysis, we used the Cochran-Armitage test for categorical variables and linear regression for continuous variables. A P value < 0.05 was considered statistically significant. To identify significant predictors of length of stay and cost, we generated 2-level hierarchical mixed effects linear regression models (with patient-level factors nested within hospitallevel factors) with the unique hospital identification number incorporated as random effects within the model. In each multivariate model, we included the following patient-level and hospital-level variables: age (per 10-year change), gender, Deyo modification of Charlson comorbidity index, primary payer, median household income category (as per patient's residential zip code), admission type (elective vs. non-elective), weekend admissions, hospital bed-size category (as per hospital's location and number of beds), hospital region (Midwest, South or West with Northeast as referent), hospital location (rural vs. urban) and hospitas teaching status (teaching vs. non-teaching). Of all the ERCPs admissions, 283,552 (69 %) had therapeutic ERCPs, 82,522 (20 %) were coded for diagnostic-only ERCPs and the remaining 45,335 (11 %) were coded as combined diagnostic and therapeutic ERCPs. There was an increase in the number of therapeutic ERCPs from 19,256 in 2002 to 29,411 in 2011 followed by a fall to 26,187 cases in 2012, which then plateaued at 26,418 in 2013 (P for trend < 0.001). A significant decrease in the diagnostic utility of ERCPs was noticed from 10,508 in 2002 to 4,496 in 2013 (P for trend < 0.001) (▶ Fig. 1 ). The most common procedure coded was endoscopic sphincterotomy (43 %) followed by endoscopic biliary stone removal (29 %) and endoscopic biliary stenting (21 %). Some of the most commonly coded diagnosis over the years included pancreatitis (14 %), biliary obstruction (12 %), and cholangitis (12 %) (▶ Table 2 ). The most common ERCP-related complications coded for included hemorrhage hematoma (3 %), respiratory failure (1.4 %) and hemorrhage requiring transfusion (1.2 %) as seen in ▶ Table 3 .
The mean LOS for patients discharged post-ERCP was 7 days (SE = 0.01). Charlson score > 2, weekend admission (▶ Fig. 2 ) admission to a large hospital, teaching hospital, and urban location were strongly predictive of extended LOS. The mean LOS was significantly higher in 2002 at 7.4 days (SE = 0.01) as compared to 6.6 days (SE = 0.02) in 2013 (P for trend < 0.001) (▶ Table 4).
After adjusting to 2016 dollars, the mean cost of hospitalization during the study period was $20,022 (SE = 41). Note that patients with Charlson score > 2, weekend admission (▶ Fig. 3 ), nad urban and teaching hospitals were independent predictors of increased cost of hospitalization during the procedure. On the contrary, elective admission and private insurance payer were associated with decreased cost of care. We also found the cost to be lowest in the southern region of the United States followed by the Midwest, West and Northeast, respectively. The mean cost significantly decreased from $19,190 (SE ▶ 18 ,219 (SE = 87) in 2013 (P for trend < 0.001) (▶ Table 5 ).
Discussion
Our study reflects contemporary data summarizing the overall trend for in-hospital ERCP over a 10-year period from 2002 to 2013. Our main findings are as follows: (1) We noted a shift in paradigm towards increasing trend for therapeutic ERCP; (2) There was a dramatic decline in diagnostic ERCPs; (3) ERCPrelated complications are minimal with low percentage of any serious complications, thus making it a relatively safe procedure; and (4) Inpatient cost of care and LOS decreased over the years during our study period, thus making it an affordable procedure. A prior study done by Mazen et al, showed a dramatic increase in the trend for overall ERCP between 1988 to 1996, followed by a dramatic drop from 1996 to 1998, which gradually leveled off by 2002 [5] . Since then ours has been the first study examining inpatient ERCPs performed for all indications. Our results are in accordance with most of the population-based studies that show steadily increasing trends in ERCP mostly driven by its therapeutic utilization and a significant drop in its diagnostic utility [6] . MRCP has led to better clinical decisionmaking by gastroenterologists, thus decreasing recommendations for ERCP [7] . Widespread availability of EUS has further led to this decline [8] . Some of the factors related to the decline in diagnostic ERCPs include the risk of post-ERCP pancreatitis, which ranges from 1.6 % to 15.7 % and can be avoided with equally sensitive modalities like EUS and MRCP without the added risk of pancreatitis [9] .
Our results demonstrated that most hospitalized patients who underwent ERCPs were older, female and predominantly white, followed by an increasing trend for ERCP among the Hispanic population. This could be explained by the predominance of biliary-pancreatic disease in the previously mentioned population [10, 11] .
Several studies have proved ERCP to be a safe and effective outpatient procedure when performed with a selective policy [12] . A few studies also showed that most ERCP complications occur within 4 to 6 hours after the procedure, thus observation alone has shown to decrease re-hospitalization rates [13 -16] . All of these factors have led to a shift in ERCP from the inpatient to the ambulatory care setting, contributing to the decline in hospital costs. Our results for in-hospital costs are in sync with the above studies.
Numerous published studies in the past have showed a "weekend effect" for various acute conditions like gastrointestinal hemorrhage, where patients admitted on weekends had worse clinical outcomes, higher hospital charges and longer LOS [17 -19] . ERCP is a technically challenging and resource-intensive procedure that may require coordination of gastroenterologists, trained nursing staff and sometimes anesthesia services, which is difficult to obtain during the weekends. Our study similarly shows an increased cost and LOS for admissions during the weekends as compared to the weekdays.
Most of the limitations of our study were inherent in use of an administrative database (NIS), which lacks the details available in trials and registries. The accuracy of coding may be questionable. Long-term outcomes, complications and re-hospitalization rates could not be assessed. We could not consider individual provider volume and could not assess rate of failure or re-hospitalization due to the use of the same diagnostic codes for both indications and complications of the procedure, like pancreatitis and cholangitis. The outcome of the procedure, degree of procedural difficulties, and endoscopy experience could not be assessed. We also could not assess the procedures conducted in the outpatient settings, which contributes to a significant number in the current era.
Conclusions
In summary, our study represents one of the first large-scale population based study in the United States conducted in the past decade. Our study indicates a significant decline in the diagnostic indications for inpatient ERCP and a steady rise in therapeutic ERCPs. This could be explained by the increasing prevalence of gall stone disease, ever evolving indications for ERCP and also the rise in safer diagnostic alternatives like endoscopic ultrasound and magnetic resonance cholangiopancreatography. Most common therapeutic procedures in our study included endoscopic sphincterotomy, followed by endoscopic biliary stone removal and endoscopic biliary stenting. Pancreatitis, biliary obstruction and cholangitis were the top 3 commonly coded diagnoses for ERCP, however, our data set prevents us from determining whether pancreatitis and cholangitis were the cause for ERCP or if these were post-procedural complications. We also identified a trend in decreasing cost for ERCP hospitalizations during our study period. That may be due to increasing elective, outpatient management of non-urgent ERCPs. Avoiding delays in weekend procedures can help us to further reduce the cost and the LOS in the hospital.
